Short answer
No major market requires a finished perfume to be patch-tested on people before sale. What the law requires is a demonstration of safety: in the EU and UK a safety assessment by a qualified assessor, in the US adequate substantiation under MoCRA. Human repeat insult patch tests (HRIPT) and in-use tests are tools an assessor may ask for to confirm that a finished product does not irritate or sensitize at its use level — never to find out whether a new material is a sensitizer, which is done without exposing people. For a perfume built within the IFRA Standards from documented materials, the assessor's paperwork review usually matters more than a patch test; a "dermatologically tested" claim, though, needs a real test behind it.
What the law actually requires
- European Union and Great Britain. A cosmetic may only be placed on the market after a safety assessment by a qualified person, recorded in a safety report. The assessor decides what evidence is needed. Testing cosmetics or their ingredients on animals is banned. See what a safety assessor needs.
- United States. MoCRA requires the responsible person to ensure and keep records of adequate safety substantiation. The FDA states that animal testing is not required to market a cosmetic and that safety data should come from scientifically robust methods. No specific test is prescribed. See MoCRA requirements.
Neither framework names the HRIPT. It is one way of generating evidence, used when an assessor judges it useful.
How the fragrance's safety is normally shown
For a perfume, most of the safety case comes from the materials, not from testing the product on people:
- Each material's safety data — the SDS, the IFRA Standards that apply to it, and the published assessments behind them.
- The IFRA check for the product's category, at its concentration (how to check IFRA limits). IFRA's limits for skin sensitizers come from a quantitative risk assessment that already includes safety factors (IFRA QRA explained).
- Allergens and restricted substances under the law of each market (the fragrance allergens list).
- Exposure — how the product is used, how much, where on the body.
- Stability and impurities — that the product stays as assessed (stability testing).
An assessor reviews these and may conclude the product is safe without any human test.
What an HRIPT is
A human repeat insult patch test exposes volunteers' skin repeatedly to a product under a patch, then checks whether a later "challenge" exposure provokes a reaction. A typical design has three phases:
- Induction — repeated patches on the same site over about three weeks;
- Rest — about two weeks with no exposure;
- Challenge — a patch on a new site, read over the following days.
Panels commonly run from about fifty to a couple of hundred people, under a dermatologist or a clinical research organization, with ethics approval and informed consent. A negative result supports the claim that the product, at the tested concentration, did not induce sensitization in that panel. It cannot prove that nobody will ever react.
Human tests are for confirming the safety of a product or concentration already expected to be safe from other data. Using them to discover whether a new material sensitizes people is considered unethical; that question is answered with non-animal methods and existing data. The EU's claims guidance points readers to the SCCS memorandum on the use of human data in sensitization risk assessment (SCCS/1567/15) for the ethical aspects.
Practical issues for perfume
- Alcohol under occlusion irritates. Labs adapt the protocol for hydroalcoholic products — for example by letting the alcohol evaporate before the patch is closed, or testing semi-occluded — and the protocol should say how.
- The tested concentration is the product's own. A pass at 15% concentrate says nothing about the same fragrance at 25%, or in a body lotion.
- A test belongs to a formula version. Change a material and the result may no longer apply; record which version was tested (version control).
- Cost and time — weeks of clinic time — make HRIPT more common for large launches than for small batches.
Claims that need a test
"Dermatologically tested", "clinically tested" or "suitable for sensitive skin" are claims about evidence. Make them only with a study that supports exactly what the words say, and keep the report. "Hypoallergenic" is a stronger claim again, and for perfume a very difficult one; see fragrance-free, unscented and hypoallergenic.
Records
- The safety assessment or substantiation file, with the formula version it covers.
- Any human study: protocol, lab, ethics approval, panel size, concentration, results, date.
- Post-market data: complaints and adverse events, which feed the assessment (complaints and adverse events).
The IFRA framework as a whole is introduced in IFRA Standards explained.
Sources
- US FDA — MoCRA: safety substantiation; animal testing not required; read October 11, 2026.
- EUR-Lex — Regulation (EC) No 1223/2009, Articles 10 and 18, Annex I (link format).
- Sub-Working Group on Claims — Technical document on cosmetic claims (version of July 3, 2017), Annex IV, which cites SCCS/1567/15; read October 11, 2026.
Frequently asked questions
Should I patch test my perfume on myself before selling it?
Wearing your own trials is normal development practice, but it is not a safety test: one person proves very little. The product's safety rests on the materials, the restriction checks and the assessor's review.
Can I say "dermatologist approved" if a dermatologist friend liked it?
No. A claim like that implies a structured evaluation; without one it is misleading.
Does an IFRA certificate replace a safety assessment?
No. IFRA's own guidance says the certificate of conformity does not replace a safety assessment or the obligation to comply with national law (IFRA certificates).
Written and reviewed by the RUŌOD Lab team. This article is general education about perfume formulation and record-keeping; it is not legal, regulatory or safety advice, and the examples are illustrations, not validated commercial formulas. How we write and check these guides.